December 2013—Biosearch Technologies has acquired a majority stake in LightSpeed Genomics, a company developing an innovative optical-detection solution for the life science and diagnostics industry based on its proprietary Synthetic Aperture Optics (SAO) technology. Biosearch and LightSpeed are collaborators on the development of StellarVision, a next-generation gene-expression platform optimized to work seamlessly with Biosearch’s Stellaris RNA FISH assays to detect and quantify single-molecule RNA targets within individual cells.
Read More »Exclusive license for TurboFISH technology, 11/13
Biosearch Technologies, a supplier of oligonucleotide components to the rapidly growing molecular diagnostics industry, announced that it has acquired worldwide rights to TurboFISH technology, a method for rapid single molecule RNA FISH. With the TurboFISH license, Biosearch maintains exclusive access to continuing Stellaris RNA FISH-based inventions from Rutgers, The State University of New Jersey.
Read More »Biosearch acquires VitraBio, DNA Technology, 7/13:106
Biosearch Technologies has acquired the oligonucleotide manufacturing division of Danish company DNA Technology and the German CPG manufacturer VitraBio. With the acquisition of DNA Technology, Biosearch adds a skilled production team with a mature quality system and an established European customer base focused in the Nordic countries.
Read More »RNA FISH technology, 4/13:87
Biosearch Technologies has acquired exclusive worldwide rights to continuing Stellaris RNA FISH-based inventions from the University of Medicine and Dentistry of New Jersey. In addition to single-molecule detection of mRNA, lncRNA, and viral RNAs, Stellaris-based methods have been extended to directly and quantitatively detect chromosomal diseases caused by translocations and aberrant splice junctions and single-nucleotide polymorphisms.
Read More »